Syensqo, a global science company developing breakthrough solutions that advance humanity, today announced it has joined MedTech Innovator (MTI), the world’s largest accelerator for medical device, digital health and diagnostic companies.
 |
MTI is a nonprofit global accelerator whose mission is to improve patients’ lives by accelerating the growth of companies transforming healthcare. Since 2013, it has supported more than 800 best-in-class startups through a model built on visibility, partnership, and mentorship, connecting innovators with a broad ecosystem across the medtech industry.
By joining MTI, Syensqo is strengthening its engagement with the startup medical device community, bringing its materials and application expertise closer to early-stage development, where design decisions can have an outsized impact on performance, manufacturability, and time-to-market.
As a partner, Syensqo joins MTI at every critical inflection point, from reviewing 1,800+ applications, to engaging with 200+ startup pitches at the Radar Forum (April 7–9) and virtual Radar pitches, participating in the Innovator Summit kickoff in June, supporting virtual accelerator programming, and connecting at the Finals Competitions in October.
Syensqo delivers one of the industry’s most comprehensive portfolios of medical-grade thermoplastics and implantable biomaterials, supporting applications from critical medical devices and equipment to long-term implantable devices. Backed by more than 60 years of high-performance polymer innovation, Syensqo’s renowned Radel® PPSU and Udel® PSU are trusted worldwide for their exceptional durability, strength and sterilization resistance. Solviva® Biomaterials - including Zeniva® PEEK, Eviva® PSU, and Veriva® PPSU - enable lightweight, radiolucent solutions for advanced implant applications. With a global presence in 30 countries and a team of 13,000 employees, Syensqo partners with medical device and equipment manufacturers through deep technical expertise and a broad materials portfolio.
